Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.

Fleroxacin (Ro 23-6240; AM-833) is a new trifluorinated quinolone exhibiting high activity against a broad spectrum of gram-negative and gram-positive bacteria. Healthy male volunteers received, according to a randomized scheme, oral doses of 200, 400, or 800 mg of fleroxacin in tablet form, an intr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Weidekamm, E, Portmann, R, Suter, K, Partos, C, Dell, D, Lücker, P W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175826/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3125788/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.12.1909
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!